Dexmedetomidine Hydrochlorid · 2,354 days since initial FDA posting
Brand: DEXMEDETOMIDINE HYDROCHLORIDE
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Unavailable
Dexmedetomidine Hydrochloride Injection: Active Shortage
Unavailable Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)
- Package NDC
- 63323-421-02
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Apr 10, 2020
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Expected recovery: TBD
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Meitheal Pharmaceuticals, Inc.
Injection
FDA reason on file: Expected recovery: TBD. General shortage guidance lives on the tracker hub.